WEKO3
AND
アイテム
{"_buckets": {"deposit": "0db469a9-ab24-4ad7-903b-89299e9cbc49"}, "_deposit": {"id": "4304", "owners": [], "pid": {"revision_id": 0, "type": "depid", "value": "4304"}, "status": "published"}, "_oai": {"id": "oai:soar-ir.repo.nii.ac.jp:00004304"}, "item_6_alternative_title_1": {"attribute_name": "\u305d\u306e\u4ed6\uff08\u5225\u8a00\u8a9e\u7b49\uff09\u306e\u30bf\u30a4\u30c8\u30eb", "attribute_value_mlt": [{"subitem_alternative_title": "A Case Report of Living-Related Renal Transplantation Accompanied by Complications Induced by Calcineurin Inhibitors"}]}, "item_6_biblio_info_6": {"attribute_name": "\u66f8\u8a8c\u60c5\u5831", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2003-02", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "1", "bibliographicPageEnd": "29", "bibliographicPageStart": "25", "bibliographicVolumeNumber": "51", "bibliographic_titles": [{"bibliographic_title": "\u4fe1\u5dde\u533b\u5b66\u96d1\u8a8c"}]}]}, "item_6_description_20": {"attribute_name": "\u6284\u9332", "attribute_value_mlt": [{"subitem_description": "A 19-year-old woman received an ABO-compatible living-related renal transplant whose donor was her\u300046-year-old mother (HLA A, B 2 match, DR 2 match), on December 9, 1999. The etiology of the patient\u0027s native kidney disease was diagnosed as chronic glomerulonephritis (sclerosing glomerulonephritis) based on\u3000renal biopsy. The induction therapy included tacrolimus(FK) and prednisolone. The first graft biopsy on the\u300027th postoperative day revealed FK-associated nephropathy(microangiopathy) because of unstable blood FK.\u3000After lowering FK blood concentration, the serum creatinine (SCr) level soon decreased from 1.2mg/dl to 0.7mg/dl.On the 40th\u3000postoperative day she developed hyperglycemia,which improved soon after the conversion of tacrolimus to cyclosporin A (CsA). The blood CsA trough level was maintained at about 100ng/ml; however, the SCr level increased up to 0.97mg/dl in May 2000. A second graft biopsy was carried out, which revealed no sign of CsA-associated nephropathy, rejection, or nephritis. However, the SCr level increased gradually to 1.2mg/dl.We therefore suspected CsA-associated functional nephropathy and gradually lowered the CsA trough level to 50ng/ml while administering mycophenolate mofetil(MMF)(2g/day). After September 2000 the SCr level was maintained between 0.7 and 0.8mg/dl. We should reconsider the past protocol for livingrelated renal transplantation based on calcineurin inhibitors and steroids.", "subitem_description_type": "Abstract"}]}, "item_6_description_30": {"attribute_name": "\u8cc7\u6e90\u30bf\u30a4\u30d7\uff08\u30b3\u30f3\u30c6\u30f3\u30c4\u306e\u7a2e\u985e\uff09", "attribute_value_mlt": [{"subitem_description": "Article", "subitem_description_type": "Other"}]}, "item_6_description_31": {"attribute_name": "\u30d5\u30a9\u30fc\u30de\u30c3\u30c8\uff1amime\u30bf\u30a4\u30d7", "attribute_value_mlt": [{"subitem_description": "application/pdf", "subitem_description_type": "Other"}]}, "item_6_description_5": {"attribute_name": "\u5f15\u7528", "attribute_value_mlt": [{"subitem_description": "\u4fe1\u5dde\u533b\u5b66\u96d1\u8a8c 51(1): 25-29(2003)", "subitem_description_type": "Other"}]}, "item_6_publisher_4": {"attribute_name": "\u51fa\u7248\u8005", "attribute_value_mlt": [{"subitem_publisher": "\u4fe1\u5dde\u533b\u5b66\u4f1a"}]}, "item_6_select_64": {"attribute_name": "\u8457\u8005\u7248\u30d5\u30e9\u30b0", "attribute_value_mlt": [{"subitem_select_item": "publisher"}]}, "item_6_source_id_35": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "0037-3826", "subitem_source_identifier_type": "ISSN"}]}, "item_6_source_id_39": {"attribute_name": "NII ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "0037-3826", "subitem_source_identifier_type": "ISSN"}]}, "item_6_source_id_40": {"attribute_name": "\u66f8\u8a8c\u30ec\u30b3\u30fc\u30c9ID", "attribute_value_mlt": [{"subitem_source_identifier": "AN00120815", "subitem_source_identifier_type": "NCID"}]}, "item_6_text_66": {"attribute_name": "sortkey", "attribute_value_mlt": [{"subitem_text_value": "05"}]}, "item_creator": {"attribute_name": "\u8457\u8005", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "\u51fa\u6d66, \u6b63"}], "nameIdentifiers": [{"nameIdentifier": "9996", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "\u5fb3\u6c38, \u771f\u4e00"}], "nameIdentifiers": [{"nameIdentifier": "9997", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "\u91cd\u677e, \u79c0\u4e00"}], "nameIdentifiers": [{"nameIdentifier": "9998", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "\u6a0b\u53e3, \u8aa0"}], "nameIdentifiers": [{"nameIdentifier": "9999", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "\u6e05\u6fa4, \u7814\u9053"}], "nameIdentifiers": [{"nameIdentifier": "10000", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "\u30d5\u30a1\u30a4\u30eb\u60c5\u5831", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2015-09-24"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "Shinshu_Med51-1-05.pdf", "filesize": [{"value": "342.0 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 342000.0, "url": {"label": "Shinshu_Med51-1-05.pdf", "url": "https://soar-ir.repo.nii.ac.jp/record/4304/files/Shinshu_Med51-1-05.pdf"}, "version_id": "b940d9f9-ccaf-4e26-a016-6a26310f0ecd"}]}, "item_keyword": {"attribute_name": "\u30ad\u30fc\u30ef\u30fc\u30c9", "attribute_value_mlt": [{"subitem_subject": "tacrolimus", "subitem_subject_scheme": "Other"}, {"subitem_subject": "cyclosporin A", "subitem_subject_scheme": "Other"}, {"subitem_subject": "mycophenolate mofetil", "subitem_subject_scheme": "Other"}, {"subitem_subject": "drug-induced nephropathy", "subitem_subject_scheme": "Other"}, {"subitem_subject": "hyperglycemia", "subitem_subject_scheme": "Other"}, {"subitem_subject": "\u30bf\u30af\u30ed\u30ea\u30e0\u30b9", "subitem_subject_scheme": "Other"}, {"subitem_subject": "\u30b5\u30a4\u30af\u30ed\u30b9\u30dd\u30ea\u30f3\uff21", "subitem_subject_scheme": "Other"}, {"subitem_subject": "\u30df\u30b3\u30d5\u30a7\u30ce\u30fc\u30eb\u9178\u30e2\u30d5\u30a7\u30c1\u30eb", "subitem_subject_scheme": "Other"}, {"subitem_subject": "\u85ac\u5264\u6027\u814e\u969c\u5bb3", "subitem_subject_scheme": "Other"}, {"subitem_subject": "\u9ad8\u8840\u7cd6", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "\u8a00\u8a9e", "attribute_value_mlt": [{"subitem_language": "jpn"}]}, "item_resource_type": {"attribute_name": "\u8cc7\u6e90\u30bf\u30a4\u30d7", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Calcineurin inhibitor\u6295\u4e0e\u6cd5\u306b\u82e6\u616e\u3057\u305f\u751f\u4f53\u814e\u79fb\u690d\u306e\uff11\u4f8b :\u30df\u30b3\u30d5\u30a7\u30ce\u30fc\u30eb\u9178\u30e2\u30d5\u30a7\u30c1\u30eb\u4f75\u7528\u306e\u6709\u7528\u6027", "item_titles": {"attribute_name": "\u30bf\u30a4\u30c8\u30eb", "attribute_value_mlt": [{"subitem_title": "Calcineurin inhibitor\u6295\u4e0e\u6cd5\u306b\u82e6\u616e\u3057\u305f\u751f\u4f53\u814e\u79fb\u690d\u306e\uff11\u4f8b :\u30df\u30b3\u30d5\u30a7\u30ce\u30fc\u30eb\u9178\u30e2\u30d5\u30a7\u30c1\u30eb\u4f75\u7528\u306e\u6709\u7528\u6027"}]}, "item_type_id": "6", "owner": "1", "path": ["461/463/464/538"], "permalink_uri": "http://hdl.handle.net/10091/9329", "pubdate": {"attribute_name": "\u516c\u958b\u65e5", "attribute_value": "2010-03-24"}, "publish_date": "2010-03-24", "publish_status": "0", "recid": "4304", "relation": {}, "relation_version_is_last": true, "title": ["Calcineurin inhibitor\u6295\u4e0e\u6cd5\u306b\u82e6\u616e\u3057\u305f\u751f\u4f53\u814e\u79fb\u690d\u306e\uff11\u4f8b :\u30df\u30b3\u30d5\u30a7\u30ce\u30fc\u30eb\u9178\u30e2\u30d5\u30a7\u30c1\u30eb\u4f75\u7528\u306e\u6709\u7528\u6027"], "weko_shared_id": null}
Calcineurin inhibitor投与法に苦慮した生体腎移植の1例 :ミコフェノール酸モフェチル併用の有用性
http://hdl.handle.net/10091/9329
2cfe1b97-f5cd-4a42-b626-9be5acd6206d
名前 / ファイル | ライセンス | アクション | |
---|---|---|---|
![]() |
|
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2010-03-24 | |||||
タイトル | ||||||
タイトル | Calcineurin inhibitor投与法に苦慮した生体腎移植の1例 :ミコフェノール酸モフェチル併用の有用性 | |||||
言語 | ||||||
言語 | jpn | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | tacrolimus | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | cyclosporin A | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | mycophenolate mofetil | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | drug-induced nephropathy | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | hyperglycemia | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | タクロリムス | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | サイクロスポリンA | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | ミコフェノール酸モフェチル | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | 薬剤性腎障害 | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | 高血糖 | |||||
資源タイプ | ||||||
資源 | http://purl.org/coar/resource_type/c_6501 | |||||
タイプ | journal article | |||||
その他(別言語等)のタイトル | ||||||
その他のタイトル | A Case Report of Living-Related Renal Transplantation Accompanied by Complications Induced by Calcineurin Inhibitors | |||||
著者 |
出浦, 正
× 出浦, 正× 徳永, 真一× 重松, 秀一× 樋口, 誠× 清澤, 研道 |
|||||
出版者 | ||||||
出版者 | 信州医学会 | |||||
引用 | ||||||
内容記述タイプ | Other | |||||
内容記述 | 信州医学雑誌 51(1): 25-29(2003) | |||||
書誌情報 |
信州医学雑誌 巻 51, 号 1, p. 25-29, 発行日 2003-02 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | A 19-year-old woman received an ABO-compatible living-related renal transplant whose donor was her 46-year-old mother (HLA A, B 2 match, DR 2 match), on December 9, 1999. The etiology of the patient's native kidney disease was diagnosed as chronic glomerulonephritis (sclerosing glomerulonephritis) based on renal biopsy. The induction therapy included tacrolimus(FK) and prednisolone. The first graft biopsy on the 27th postoperative day revealed FK-associated nephropathy(microangiopathy) because of unstable blood FK. After lowering FK blood concentration, the serum creatinine (SCr) level soon decreased from 1.2mg/dl to 0.7mg/dl.On the 40th postoperative day she developed hyperglycemia,which improved soon after the conversion of tacrolimus to cyclosporin A (CsA). The blood CsA trough level was maintained at about 100ng/ml; however, the SCr level increased up to 0.97mg/dl in May 2000. A second graft biopsy was carried out, which revealed no sign of CsA-associated nephropathy, rejection, or nephritis. However, the SCr level increased gradually to 1.2mg/dl.We therefore suspected CsA-associated functional nephropathy and gradually lowered the CsA trough level to 50ng/ml while administering mycophenolate mofetil(MMF)(2g/day). After September 2000 the SCr level was maintained between 0.7 and 0.8mg/dl. We should reconsider the past protocol for livingrelated renal transplantation based on calcineurin inhibitors and steroids. | |||||
資源タイプ(コンテンツの種類) | ||||||
内容記述タイプ | Other | |||||
内容記述 | Article | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 0037-3826 | |||||
書誌レコードID | ||||||
収録物識別子タイプ | NCID | |||||
収録物識別子 | AN00120815 |